Literature DB >> 27825289

Vitamin D Deficiency in Traumatic Brain Injury and Its Relationship with Severity of Injury and Quality of Life: A Prospective, Observational Study.

Emma Toman1, Jonathon R B Bishop2, David J Davies3, Zhangjie Su4, Sherwin Criseno5, Andrea Mason5, Andrew A Toogood5, Antonio Belli6.   

Abstract

This single-center prospective observational study aims to describe the prevalence of vitamin D deficiency (VDD) in the traumatic brain injury (TBI) population and identify any relationship between vitamin D and severity of head injury or quality of life. One hundred twenty-four TBI patients had serum vitamin D (25-OHD) levels measured at the local post-TBI endocrine screening clinic over 20 months. Quality of Life after Brain Injury questionnaires were completed by the patient concurrently. A multivariate regressional analysis was performed, controlling for age, season, ethnicity, time since injury, TBI severity, and gender. A total of 34% (n = 42) of the cohort were vitamin D deficient (25-OHD <25 nmol/L), with a further 23% (n = 29) having insufficient levels (25-OHD 25-50 nmol/L). Vitamin D was significantly lower in patients with severe TBI than in patients with mild TBI (n = 95; p = 0.03; confidence interval [CI] 95% -23.60 to -1.21; mean effect size 12.40 nmol/L). There was a trend for self-reported quality of life to be better in patients with optimum vitamin D levels than in patients with deficient vitamin D levels, controlling for severity of injury (n = 81; p = 0.05; CI 95% -0.07 to 21.27). This is the first study to identify a significant relationship between vitamin D levels and severity of head injury. Clinicians should actively screen for and treat VDD in head-injured patients to reduce the risk of further morbidity, such as osteomalacia and cardiovascular disease. Future research should establish the natural history of vitamin D levels following TBI to identify at which stage VDD develops and whether vitamin D replacement could have a beneficial effect on recovery and quality of life.

Entities:  

Keywords:  endocrinology; neurotrauma; traumatic brain injury; vitamin D; vitamin D deficiency

Mesh:

Substances:

Year:  2016        PMID: 27825289     DOI: 10.1089/neu.2016.4494

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  6 in total

1.  Vitamin D serum level in subjects with critical illness polyneuropathy and myopathy.

Authors:  Domenico Intiso; Andrea Fontana; Massimiliano Copetti; Luigi Amoruso; Michelangelo Bartolo; Andrea Santamato; Filomena Di Rienzo
Journal:  J Musculoskelet Neuronal Interact       Date:  2020-03-03       Impact factor: 2.041

2.  iTRAQ-based proteomic profiling reveals protein alterations after traumatic brain injury and supports thyroxine as a potential treatment.

Authors:  Zhongxiang Zhang; Jiangtao Yu; Pengcheng Wang; Lian Lin; Ruining Liu; Rong Zeng; Haoli Ma; Yan Zhao
Journal:  Mol Brain       Date:  2021-01-27       Impact factor: 4.041

Review 3.  Benefits of vitamin D supplementation to attenuate TBI secondary injury?

Authors:  Kiana Saadatmand; Saba Khan; Quaratulain Hassan; Raymond Hautamaki; Rani Ashouri; Josh Lua; Sylvain Doré
Journal:  Transl Neurosci       Date:  2021-12-15       Impact factor: 1.757

4.  Vitamin D Protects against Traumatic Brain Injury via Modulating TLR4/MyD88/NF-κB Pathway-Mediated Microglial Polarization and Neuroinflammation.

Authors:  Hongsheng Jiang; Xinyu Yang; Yanzhou Wang; Caifeng Zhou
Journal:  Biomed Res Int       Date:  2022-07-15       Impact factor: 3.246

Review 5.  Is Vitamin D Deficiency Implicated in Autonomic Dysfunction?

Authors:  Rozina Wadhwania
Journal:  J Pediatr Neurosci       Date:  2017 Apr-Jun

6.  Quality of life measures in older adults after traumatic brain injury: a systematic review.

Authors:  Cindy Hunt; Shatabdy Zahid; Naomi Ennis; Alicja Michalak; Cheryl Masanic; Chantal Vaidyanath; Shree Bhalerao; Michael D Cusimano; Andrew Baker
Journal:  Qual Life Res       Date:  2019-09-14       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.